tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Acorda Therapeutics's activity chart (see below) currently has 40 price targets and 27 ratings on display.
Analysts average stock forecasts to be materialized ratio is 61.43% with an average time for these price targets to be met of 87.57 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 17-Jun-2021. First documented stock forecast 24-Sep-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$200
$198.8 (16566.67%)
$3960
5 years 2 months 25 days ago
(17-Jun-2021)
0/4 (0%)
$103 (106.19%)
Buy
$100
$98.8 (8233.33%)
$3600
5 years 7 months 29 days ago
(13-Jan-2021)
2/4 (50%)
$-22.4 (-18.30%)
139
Hold
$120
$118.8 (9900.00%)
$2280
6 years 4 months 5 days ago
(06-May-2020)
5/5 (100%)
$16.79 (16.27%)
44
Hold
$120
$118.8 (9900.00%)
$3000
6 years 4 months 5 days ago
(06-May-2020)
6/6 (100%)
$16.79 (16.27%)
45
Sell
$120
$118.8 (9900.00%)
$1200
6 years 10 months 21 days ago
(21-Oct-2019)
7/7 (100%)
$-165.6 (-57.98%)
161
What is ACOR (Acorda Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ACOR (Acorda Therapeutics)?
Which analyst has the current lower performing score on ACOR (Acorda Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ACOR (Acorda Therapeutics)?
Which analyst is the currently most bullish on ACOR (Acorda Therapeutics)?
Which analyst is the currently most reserved on ACOR (Acorda Therapeutics)?
